I don't have the time to write a post about this transaction at the moment, but here is a collection of links related to this deal in the RNAi space (relevant to Alnylam...(
read more)
Arrowhead Research Corporation's (NASDAQ: ARWR) President and Chief Executive Officer today issued the following open letter to the Company's shareholders:
Highlights:
Let us start with an overview of some of Arrowhead's...(
read more)